Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 155

1.

Recent Developments in TSPO PET Imaging as A Biomarker of Neuroinflammation in Neurodegenerative Disorders.

Werry EL, Bright FM, Piguet O, Ittner LM, Halliday GM, Hodges JR, Kiernan MC, Loy CT, Kril JJ, Kassiou M.

Int J Mol Sci. 2019 Jun 28;20(13). pii: E3161. doi: 10.3390/ijms20133161. Review.

2.

Cellular and regional vulnerability in frontotemporal tauopathies.

Forrest SL, Kril JJ, Halliday GM.

Acta Neuropathol. 2019 Jun 15. doi: 10.1007/s00401-019-02035-7. [Epub ahead of print] Review.

PMID:
31203391
3.

Coexisting Lewy body disease and clinical parkinsonism in frontotemporal lobar degeneration.

Forrest SL, Crockford DR, Sizemova A, McCann H, Shepherd CE, McGeachie AB, Affleck AJ, Carew-Jones F, Bartley L, Kwok JB, Kim WS, Jary E, Tan RH, McGinley CV, Piguet O, Hodges JR, Kril JJ, Halliday GM.

Neurology. 2019 May 21;92(21):e2472-e2482. doi: 10.1212/WNL.0000000000007530. Epub 2019 Apr 24.

PMID:
31019099
4.

Chronic Traumatic Encephalopathy (CTE) Is Absent From a European Community-Based Aging Cohort While Cortical Aging-Related Tau Astrogliopathy (ARTAG) Is Highly Prevalent.

Forrest SL, Kril JJ, Wagner S, Hönigschnabl S, Reiner A, Fischer P, Kovacs GG.

J Neuropathol Exp Neurol. 2019 May 1;78(5):398-405. doi: 10.1093/jnen/nlz017.

PMID:
30939193
5.

The relationship between the morphological subtypes of microglia and Alzheimer's disease neuropathology.

Paasila PJ, Davies DS, Kril JJ, Goldsbury C, Sutherland GT.

Brain Pathol. 2019 Feb 25. doi: 10.1111/bpa.12717. [Epub ahead of print]

PMID:
30803086
6.

The underacknowledged PPA-ALS: A unique clinicopathologic subtype with strong heritability.

Tan RH, Guennewig B, Dobson-Stone C, Kwok JBJ, Kril JJ, Kiernan MC, Hodges JR, Piguet O, Halliday GM.

Neurology. 2019 Mar 19;92(12):e1354-e1366. doi: 10.1212/WNL.0000000000007146. Epub 2019 Feb 15.

PMID:
30770429
7.

Heritability in frontotemporal tauopathies.

Forrest SL, Halliday GM, McCann H, McGeachie AB, McGinley CV, Hodges JR, Piguet O, Kwok JB, Spillantini MG, Kril JJ.

Alzheimers Dement (Amst). 2019 Jan 24;11:115-124. doi: 10.1016/j.dadm.2018.12.001. eCollection 2019 Dec.

8.

Re-investigating the effects of chronic smoking on the pathology of alcohol-related human brain damage.

McCorkindale AN, Sizemova A, Sheedy D, Kril JJ, Sutherland GT.

Alcohol. 2019 May;76:11-14. doi: 10.1016/j.alcohol.2018.07.001. Epub 2018 Jul 11.

PMID:
30529017
9.

Impact of small vessel disease on severity of motor and cognitive impairment in Parkinson's disease.

Schwartz RS, Halliday GM, Soh D, Cordato DJ, Kril JJ.

J Clin Neurosci. 2018 Dec;58:70-74. doi: 10.1016/j.jocn.2018.10.029. Epub 2018 Oct 14.

PMID:
30327218
10.

Reply: Will FTLD-tau work for all when FTDP-17 retires?

Forrest SL, Kril JJ, Halliday GM.

Brain. 2018 Aug 1;141(8):e63. doi: 10.1093/brain/awy179. No abstract available.

PMID:
29947744
11.

Imaging mass spectrometry of frontal white matter lipid changes in human alcoholics.

de la Monte SM, Kay J, Yalcin EB, Kril JJ, Sheedy D, Sutherland GT.

Alcohol. 2018 Mar;67:51-63. doi: 10.1016/j.alcohol.2017.08.004. Epub 2017 Aug 17.

12.

Retiring the term FTDP-17 as MAPT mutations are genetic forms of sporadic frontotemporal tauopathies.

Forrest SL, Kril JJ, Stevens CH, Kwok JB, Hallupp M, Kim WS, Huang Y, McGinley CV, Werka H, Kiernan MC, Götz J, Spillantini MG, Hodges JR, Ittner LM, Halliday GM.

Brain. 2018 Feb 1;141(2):521-534. doi: 10.1093/brain/awx328. Erratum in: Brain. 2018 Apr 1;141(4):e30.

13.

Assessment of amyloid β in pathologically confirmed frontotemporal dementia syndromes.

Tan RH, Kril JJ, Yang Y, Tom N, Hodges JR, Villemagne VL, Rowe CC, Leyton CE, Kwok JBJ, Ittner LM, Halliday GM.

Alzheimers Dement (Amst). 2017 May 29;9:10-20. doi: 10.1016/j.dadm.2017.05.005. eCollection 2017.

14.

Multisite Assessment of Aging-Related Tau Astrogliopathy (ARTAG).

Kovacs GG, Xie SX, Lee EB, Robinson JL, Caswell C, Irwin DJ, Toledo JB, Johnson VE, Smith DH, Alafuzoff I, Attems J, Bencze J, Bieniek KF, Bigio EH, Bodi I, Budka H, Dickson DW, Dugger BN, Duyckaerts C, Ferrer I, Forrest SL, Gelpi E, Gentleman SM, Giaccone G, Grinberg LT, Halliday GM, Hatanpaa KJ, Hof PR, Hofer M, Hortobágyi T, Ironside JW, King A, Kofler J, Kövari E, Kril JJ, Love S, Mackenzie IR, Mao Q, Matej R, McLean C, Munoz DG, Murray ME, Neltner J, Nelson PT, Ritchie D, Rodriguez RD, Rohan Z, Rozemuller A, Sakai K, Schultz C, Seilhean D, Smith V, Tacik P, Takahashi H, Takao M, Rudolf Thal D, Weis S, Wharton SB, White CL 3rd, Woulfe JM, Yamada M, Trojanowski JQ.

J Neuropathol Exp Neurol. 2017 Jul 1;76(7):605-619. doi: 10.1093/jnen/nlx041.

15.

Response to: Comment on 'Human adult neurogenesis across the ages: An immunohistochemical study'.

Dennis CV, Suh LS, Rodriguez ML, Kril JJ, Sutherland GT.

Neuropathol Appl Neurobiol. 2017 Aug;43(5):452-454. doi: 10.1111/nan.12394. No abstract available.

PMID:
28218954
16.

The Differential Effects of Alcohol and Nicotine-Specific Nitrosamine Ketone on White Matter Ultrastructure.

Papp-Peka A, Tong M, Kril JJ, De La Monte SM, Sutherland GT.

Alcohol Alcohol. 2017 Mar 9;52(2):165-171. doi: 10.1093/alcalc/agw067. No abstract available.

17.

[18F]AV-1451 PET in behavioral variant frontotemporal dementia due to MAPT mutation.

Bevan Jones WR, Cope TE, Passamonti L, Fryer TD, Hong YT, Aigbirhio F, Kril JJ, Forrest SL, Allinson K, Coles JP, Simon Jones P, Spillantini MG, Hodges JR, O'Brien JT, Rowe JB.

Ann Clin Transl Neurol. 2016 Oct 18;3(12):940-947. doi: 10.1002/acn3.366. eCollection 2016 Dec.

18.

Mouse models of frontotemporal dementia: A comparison of phenotypes with clinical symptomatology.

Ahmed RM, Irish M, van Eersel J, Ittner A, Ke YD, Volkerling A, van der Hoven J, Tanaka K, Karl T, Kassiou M, Kril JJ, Piguet O, Götz J, Kiernan MC, Halliday GM, Hodges JR, Ittner LM.

Neurosci Biobehav Rev. 2017 Mar;74(Pt A):126-138. doi: 10.1016/j.neubiorev.2017.01.004. Epub 2017 Jan 11. Review.

PMID:
28088537
19.

Cortical grey matter volume reduction in people with schizophrenia is associated with neuro-inflammation.

Zhang Y, Catts VS, Sheedy D, McCrossin T, Kril JJ, Shannon Weickert C.

Transl Psychiatry. 2016 Dec 13;6(12):e982. doi: 10.1038/tp.2016.238.

20.

Site-specific phosphorylation of tau inhibits amyloid-β toxicity in Alzheimer's mice.

Ittner A, Chua SW, Bertz J, Volkerling A, van der Hoven J, Gladbach A, Przybyla M, Bi M, van Hummel A, Stevens CH, Ippati S, Suh LS, Macmillan A, Sutherland G, Kril JJ, Silva AP, Mackay JP, Poljak A, Delerue F, Ke YD, Ittner LM.

Science. 2016 Nov 18;354(6314):904-908.

PMID:
27856911
21.

Expanding the phenotypic associations of globular glial tau subtypes.

Burrell JR, Forrest S, Bak TH, Hodges JR, Halliday GM, Kril JJ.

Alzheimers Dement (Amst). 2016 Apr 8;4:6-13. doi: 10.1016/j.dadm.2016.03.006. eCollection 2016.

22.

Human adult neurogenesis across the ages: An immunohistochemical study.

Dennis CV, Suh LS, Rodriguez ML, Kril JJ, Sutherland GT.

Neuropathol Appl Neurobiol. 2016 Dec;42(7):621-638. doi: 10.1111/nan.12337. Epub 2016 Aug 28.

23.

Motor cortical function determines prognosis in sporadic ALS.

Shibuya K, Park SB, Geevasinga N, Menon P, Howells J, Simon NG, Huynh W, Noto Y, Götz J, Kril JJ, Ittner LM, Hodges J, Halliday G, Vucic S, Kiernan MC.

Neurology. 2016 Aug 2;87(5):513-20. doi: 10.1212/WNL.0000000000002912. Epub 2016 Jul 8.

PMID:
27402895
24.

TDP-43 in the hypoglossal nucleus identifies amyotrophic lateral sclerosis in behavioral variant frontotemporal dementia.

Halliday GM, Kiernan MC, Kril JJ, Mito R, Masuda-Suzukake M, Hasegawa M, McCann H, Bartley L, Dobson-Stone C, Kwok JBJ, Hornberger M, Hodges JR, Tan RH.

J Neurol Sci. 2016 Jul 15;366:197-201. doi: 10.1016/j.jns.2016.05.005. Epub 2016 May 4.

PMID:
27288806
25.

The effects of chronic smoking on the pathology of alcohol-related brain damage.

McCorkindale AN, Sheedy D, Kril JJ, Sutherland GT.

Alcohol. 2016 Jun;53:35-44. doi: 10.1016/j.alcohol.2016.04.002. Epub 2016 Apr 30.

26.

The NSW brain tissue resource centre: Banking for alcohol and major neuropsychiatric disorders research.

Sutherland GT, Sheedy D, Stevens J, McCrossin T, Smith CC, van Roijen M, Kril JJ.

Alcohol. 2016 May;52:33-39. doi: 10.1016/j.alcohol.2016.02.005. Epub 2016 Mar 14.

27.

The bvFTD phenocopy syndrome: a clinicopathological report.

Devenney E, Forrest SL, Xuereb J, Kril JJ, Hodges JR.

J Neurol Neurosurg Psychiatry. 2016 Oct;87(10):1155-6. doi: 10.1136/jnnp-2015-312826. Epub 2016 Apr 15. No abstract available.

PMID:
27083530
28.

The frontotemporal dementia-motor neuron disease continuum.

Burrell JR, Halliday GM, Kril JJ, Ittner LM, Götz J, Kiernan MC, Hodges JR.

Lancet. 2016 Aug 27;388(10047):919-31. doi: 10.1016/S0140-6736(16)00737-6. Epub 2016 Mar 14. Review.

PMID:
26987909
29.

Distinctive pathological mechanisms involved in primary progressive aphasias.

Leyton CE, Britton AK, Hodges JR, Halliday GM, Kril JJ.

Neurobiol Aging. 2016 Feb;38:82-92. doi: 10.1016/j.neurobiolaging.2015.10.017. Epub 2015 Oct 26.

PMID:
26827646
30.

Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy.

Kovacs GG, Ferrer I, Grinberg LT, Alafuzoff I, Attems J, Budka H, Cairns NJ, Crary JF, Duyckaerts C, Ghetti B, Halliday GM, Ironside JW, Love S, Mackenzie IR, Munoz DG, Murray ME, Nelson PT, Takahashi H, Trojanowski JQ, Ansorge O, Arzberger T, Baborie A, Beach TG, Bieniek KF, Bigio EH, Bodi I, Dugger BN, Feany M, Gelpi E, Gentleman SM, Giaccone G, Hatanpaa KJ, Heale R, Hof PR, Hofer M, Hortobágyi T, Jellinger K, Jicha GA, Ince P, Kofler J, Kövari E, Kril JJ, Mann DM, Matej R, McKee AC, McLean C, Milenkovic I, Montine TJ, Murayama S, Lee EB, Rahimi J, Rodriguez RD, Rozemüller A, Schneider JA, Schultz C, Seeley W, Seilhean D, Smith C, Tagliavini F, Takao M, Thal DR, Toledo JB, Tolnay M, Troncoso JC, Vinters HV, Weis S, Wharton SB, White CL 3rd, Wisniewski T, Woulfe JM, Yamada M, Dickson DW.

Acta Neuropathol. 2016 Jan;131(1):87-102. doi: 10.1007/s00401-015-1509-x. Epub 2015 Dec 10. Review.

31.

Cerebellar neuronal loss in amyotrophic lateral sclerosis cases with ATXN2 intermediate repeat expansions.

Tan RH, Kril JJ, McGinley C, Hassani M, Masuda-Suzukake M, Hasegawa M, Mito R, Kiernan MC, Halliday GM.

Ann Neurol. 2016 Feb;79(2):295-305. doi: 10.1002/ana.24565. Epub 2016 Jan 14.

PMID:
26599997
32.

Cortical Function in Asymptomatic Carriers and Patients With C9orf72 Amyotrophic Lateral Sclerosis.

Geevasinga N, Menon P, Nicholson GA, Ng K, Howells J, Kril JJ, Yiannikas C, Kiernan MC, Vucic S.

JAMA Neurol. 2015 Nov;72(11):1268-74. doi: 10.1001/jamaneurol.2015.1872.

33.

TDP-43 proteinopathies: pathological identification of brain regions differentiating clinical phenotypes.

Tan RH, Kril JJ, Fatima M, McGeachie A, McCann H, Shepherd C, Forrest SL, Affleck A, Kwok JB, Hodges JR, Kiernan MC, Halliday GM.

Brain. 2015 Oct;138(Pt 10):3110-22. doi: 10.1093/brain/awv220. Epub 2015 Jul 31.

PMID:
26231953
34.

Spread of pathology in amyotrophic lateral sclerosis: assessment of phosphorylated TDP-43 along axonal pathways.

Fatima M, Tan R, Halliday GM, Kril JJ.

Acta Neuropathol Commun. 2015 Jul 28;3:47. doi: 10.1186/s40478-015-0226-y.

35.

Is the logopenic-variant of primary progressive aphasia a unitary disorder?

Leyton CE, Hodges JR, McLean CA, Kril JJ, Piguet O, Ballard KJ.

Cortex. 2015 Jun;67:122-33. doi: 10.1016/j.cortex.2015.03.011. Epub 2015 Apr 1.

PMID:
25955499
36.

FTD and ALS--translating mouse studies into clinical trials.

Ittner LM, Halliday GM, Kril JJ, Götz J, Hodges JR, Kiernan MC.

Nat Rev Neurol. 2015 Jun;11(6):360-6. doi: 10.1038/nrneurol.2015.65. Epub 2015 May 5. Review.

PMID:
25939274
37.

Early-onset axonal pathology in a novel P301S-Tau transgenic mouse model of frontotemporal lobar degeneration.

van Eersel J, Stevens CH, Przybyla M, Gladbach A, Stefanoska K, Chan CK, Ong WY, Hodges JR, Sutherland GT, Kril JJ, Abramowski D, Staufenbiel M, Halliday GM, Ittner LM.

Neuropathol Appl Neurobiol. 2015 Dec;41(7):906-25. doi: 10.1111/nan.12233. Epub 2015 May 30.

PMID:
25763777
38.

Neuropathology of alcoholism.

Sutherland GT, Sheedy D, Kril JJ.

Handb Clin Neurol. 2014;125:603-15. doi: 10.1016/B978-0-444-62619-6.00035-5. Review.

PMID:
25307599
39.

The alternative splicing of the apolipoprotein E gene is unperturbed in the brains of Alzheimer's disease patients.

Mills JD, Sheahan PJ, Lai D, Kril JJ, Janitz M, Sutherland GT.

Mol Biol Rep. 2014 Oct;41(10):6365-76. doi: 10.1007/s11033-014-3516-8. Epub 2014 Jul 5.

PMID:
24996286
40.

Beyond the temporal pole: limbic memory circuit in the semantic variant of primary progressive aphasia.

Tan RH, Wong S, Kril JJ, Piguet O, Hornberger M, Hodges JR, Halliday GM.

Brain. 2014 Jul;137(Pt 7):2065-76. doi: 10.1093/brain/awu118. Epub 2014 May 19.

PMID:
24844729
41.

Comorbidities, confounders, and the white matter transcriptome in chronic alcoholism.

Sutherland GT, Sheedy D, Sheahan PJ, Kaplan W, Kril JJ.

Alcohol Clin Exp Res. 2014 Apr;38(4):994-1001. doi: 10.1111/acer.12341. Epub 2014 Jan 24.

42.

New criteria for frontotemporal dementia syndromes: clinical and pathological diagnostic implications.

Chare L, Hodges JR, Leyton CE, McGinley C, Tan RH, Kril JJ, Halliday GM.

J Neurol Neurosurg Psychiatry. 2014 Aug;85(8):865-70. doi: 10.1136/jnnp-2013-306948. Epub 2014 Jan 13.

PMID:
24421286
43.

Human alcohol-related neuropathology.

de la Monte SM, Kril JJ.

Acta Neuropathol. 2014 Jan;127(1):71-90. doi: 10.1007/s00401-013-1233-3. Epub 2013 Dec 27. Review.

44.

Microglial proliferation in the brain of chronic alcoholics with hepatic encephalopathy.

Dennis CV, Sheahan PJ, Graeber MB, Sheedy DL, Kril JJ, Sutherland GT.

Metab Brain Dis. 2014 Dec;29(4):1027-39. doi: 10.1007/s11011-013-9469-0. Epub 2013 Dec 19.

45.

Classification of FTLD-TDP cases into pathological subtypes using antibodies against phosphorylated and non-phosphorylated TDP43.

Tan RH, Shepherd CE, Kril JJ, McCann H, McGeachie A, McGinley C, Affleck A, Halliday GM.

Acta Neuropathol Commun. 2013 Jul 10;1:33. doi: 10.1186/2051-5960-1-33.

46.

The pathogenesis of cingulate atrophy in behavioral variant frontotemporal dementia and Alzheimer's disease.

Tan RH, Pok K, Wong S, Brooks D, Halliday GM, Kril JJ.

Acta Neuropathol Commun. 2013 Jul 5;1:30. doi: 10.1186/2051-5960-1-30.

47.

Distribution of pathology in frontal variant Alzheimer's disease.

Blennerhassett R, Lillo P, Halliday GM, Hodges JR, Kril JJ.

J Alzheimers Dis. 2014;39(1):63-70. doi: 10.3233/JAD-131241.

PMID:
24121962
48.

Using autopsy brain tissue to study alcohol-related brain damage in the genomic age.

Sutherland GT, Sheedy D, Kril JJ.

Alcohol Clin Exp Res. 2014 Jan;38(1):1-8. doi: 10.1111/acer.12243. Epub 2013 Aug 27. Review.

49.

The effects of chronic alcoholism on cell proliferation in the human brain.

Sutherland GT, Sheahan PJ, Matthews J, Dennis CV, Sheedy DS, McCrossin T, Curtis MA, Kril JJ.

Exp Neurol. 2013 Sep;247:9-18. doi: 10.1016/j.expneurol.2013.03.020. Epub 2013 Mar 28.

50.

Increased apolipoprotein D dimer formation in Alzheimer's disease hippocampus is associated with lipid conjugated diene levels.

Bhatia S, Jenner AM, Li H, Ruberu K, Spiro AS, Shepherd CE, Kril JJ, Kain N, Don A, Garner B.

J Alzheimers Dis. 2013;35(3):475-86. doi: 10.3233/JAD-122278.

PMID:
23455990

Supplemental Content

Support Center